26.86
price down icon5.39%   -1.53
pre-market  Pre-market:  27.00   0.14   +0.52%
loading
Centene Corp stock is traded at $26.86, with a volume of 21.36M. It is down -5.39% in the last 24 hours and down -50.25% over the past month. Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$28.39
Open:
$28.16
24h Volume:
21.36M
Relative Volume:
1.93
Market Cap:
$13.37B
Revenue:
$163.07B
Net Income/Loss:
$3.31B
P/E Ratio:
4.3045
EPS:
6.24
Net Cash Flow:
$-490.00M
1W Performance:
-2.08%
1M Performance:
-50.25%
6M Performance:
-58.50%
1Y Performance:
-63.26%
1-Day Range:
Value
$26.82
$28.37
1-Week Range:
Value
$26.25
$29.51
52-Week Range:
Value
$26.25
$80.59

Centene Corp Stock (CNC) Company Profile

Name
Name
Centene Corp
Name
Phone
(314) 725-4477
Name
Address
7700 FORSYTH BLVD., ST LOUIS
Name
Employee
60,500
Name
Twitter
@Centene
Name
Next Earnings Date
2025-07-25
Name
Latest SEC Filings
Name
CNC's Discussions on Twitter

Compare CNC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Healthcare Plans icon
CNC
Centene Corp
26.86 13.94B 163.07B 3.31B -490.00M 6.24
Healthcare Plans icon
UNH
Unitedhealth Group Inc
282.12 254.96B 410.06B 22.11B 24.86B 23.88
Healthcare Plans icon
CI
Cigna Group
292.39 79.17B 254.47B 5.03B 6.01B 18.06
Healthcare Plans icon
CVS
Cvs Health Corp
59.64 76.79B 378.96B 5.28B 5.94B 4.19
Healthcare Plans icon
ELV
Elevance Health Inc
285.98 65.10B 189.25B 5.36B 5.34B 23.50
Healthcare Plans icon
HUM
Humana Inc
231.52 28.72B 117.76B 1.21B 2.39B 9.95

Centene Corp Stock (CNC) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-23-25 Downgrade Wells Fargo Overweight → Equal Weight
Jul-21-25 Downgrade TD Cowen Buy → Hold
Jul-16-25 Downgrade BofA Securities Neutral → Underperform
Jul-10-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-02-25 Downgrade JP Morgan Overweight → Neutral
Jul-02-25 Downgrade UBS Buy → Neutral
Jun-09-25 Resumed Morgan Stanley Overweight
Jun-02-25 Downgrade Barclays Overweight → Equal Weight
Apr-08-25 Upgrade Jefferies Underperform → Hold
Feb-06-25 Downgrade Argus Buy → Hold
Dec-17-24 Resumed JP Morgan Overweight
Dec-13-24 Upgrade UBS Neutral → Buy
Dec-10-24 Downgrade Jefferies Hold → Underperform
Jul-24-24 Downgrade Jefferies Buy → Hold
May-30-24 Initiated Robert W. Baird Neutral
Mar-21-24 Downgrade Stephens Overweight → Equal-Weight
Mar-06-24 Initiated Barclays Overweight
Jan-02-24 Upgrade Wells Fargo Equal Weight → Overweight
Sep-05-23 Upgrade BofA Securities Underperform → Neutral
Aug-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-12-23 Downgrade Wolfe Research Outperform → Peer Perform
Jun-20-23 Initiated UBS Neutral
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Mar-08-23 Downgrade Deutsche Bank Buy → Hold
Feb-23-23 Downgrade JP Morgan Overweight → Neutral
Dec-13-22 Downgrade BofA Securities Neutral → Underperform
Sep-30-22 Initiated Argus Buy
Aug-26-22 Downgrade Wells Fargo Overweight → Equal Weight
Jul-28-22 Resumed Barclays Overweight
Jul-14-22 Upgrade Jefferies Hold → Buy
Jun-21-22 Upgrade Credit Suisse Neutral → Outperform
Jun-17-22 Initiated Loop Capital Buy
May-27-22 Resumed Bernstein Outperform
May-26-22 Downgrade BofA Securities Buy → Neutral
Jan-07-22 Resumed Barclays Overweight
Jan-06-22 Resumed JP Morgan Overweight
Dec-14-21 Initiated Goldman Neutral
Dec-13-21 Reiterated BMO Capital Markets Outperform
Dec-13-21 Reiterated BofA Securities Buy
Dec-13-21 Reiterated Credit Suisse Neutral
Dec-13-21 Reiterated Mizuho Neutral
Dec-13-21 Reiterated Oppenheimer Outperform
Dec-13-21 Reiterated Stephens Overweight
Dec-13-21 Reiterated Truist Buy
Dec-13-21 Reiterated Wells Fargo Overweight
Dec-13-21 Reiterated Wolfe Research Outperform
Nov-01-21 Downgrade Citigroup Buy → Neutral
Sep-10-21 Initiated Cowen Outperform
Jul-09-21 Initiated Seaport Global Securities Buy
May-19-21 Initiated Wells Fargo Overweight
May-11-21 Upgrade Stephens Equal-Weight → Overweight
Mar-10-21 Initiated Mizuho Neutral
Jan-21-21 Resumed Goldman Neutral
Jan-15-21 Downgrade Jefferies Buy → Hold
Sep-22-20 Downgrade Stephens Overweight → Equal-Weight
Jul-01-20 Initiated SVB Leerink Outperform
Feb-05-20 Upgrade JP Morgan Neutral → Overweight
Feb-03-20 Resumed Evercore ISI Outperform
Jan-28-20 Reiterated Bernstein Outperform
Jan-06-20 Upgrade Wolfe Research Peer Perform → Outperform
Sep-12-19 Initiated Deutsche Bank Buy
May-10-19 Upgrade Citigroup Neutral → Buy
Jan-14-19 Initiated Stephens Overweight
Oct-24-18 Upgrade Leerink Partners Mkt Perform → Outperform
Jul-18-18 Resumed Citigroup Neutral
Dec-18-17 Reiterated Jefferies Buy
Sep-13-17 Reiterated Leerink Partners Mkt Perform
Jun-07-17 Initiated Morgan Stanley Overweight
May-22-17 Downgrade JP Morgan Overweight → Neutral
Apr-05-17 Initiated Deutsche Bank Buy
Mar-23-17 Downgrade Citigroup Buy → Neutral
Feb-08-17 Reiterated Barclays Overweight
Feb-07-17 Resumed Cantor Fitzgerald Overweight
Jan-04-17 Initiated Piper Jaffray Overweight
View All

Centene Corp Stock (CNC) Latest News

pulisher
Jul 28, 2025

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - GlobeNewswire Inc.

Jul 28, 2025
pulisher
Jul 28, 2025

Centene Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jul 28, 2025
pulisher
Jul 28, 2025

Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde – Company AnnouncementFT.com - Financial Times

Jul 28, 2025
pulisher
Jul 28, 2025

CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com

Jul 28, 2025
pulisher
Jul 28, 2025

Centene Corporation (CNC) Cuts Outlook After $1.8B ACA Revenue Hit - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

Tapestry To Rally Around 34%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

Cantor Fitzgerald downgrades Centene stock rating to Neutral on HIX uncertainty - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Centene Slashes 2025 Guidance and Posts Surprise Loss - Mint

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Centene Corporation company’s balance sheetAchieve exceptional returns with expert guidance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

CNC Investors with Losses Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit - Barchart.com

Jul 27, 2025
pulisher
Jul 27, 2025

CNC INVESTOR ALERT: Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

Jul 27, 2025
pulisher
Jul 27, 2025

Centene Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co

Jul 27, 2025
pulisher
Jul 27, 2025

CNC STOCK REMINDER: BFA Law Reminds Centene Corporation Investors with Losses to Contact the Firm by September 8 Legal Deadline - Newsfile

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Centene Corporation stockFree Buy/Sell Signal Notifications - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Centene Corporation stock attracts strong analyst attentionReal Time Breakout Tracking - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Centene reports a rare loss as medical costs surge, and the stock hits a decade low - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

Centene Reports Loss, Citing Rising Medical Costs - The Wall Street Journal

Jul 26, 2025
pulisher
Jul 26, 2025

Centene: Q2 Earnings Snapshot - CTPost

Jul 26, 2025
pulisher
Jul 26, 2025

Earnings call transcript: Centene Q2 2025 results reveal EPS miss, stock rises - Investing.com

Jul 26, 2025
pulisher
Jul 26, 2025

Earnings call transcript: Centene Q2 2025 results reveal EPS miss, stock rises By Investing.com - Investing.com South Africa

Jul 26, 2025
pulisher
Jul 26, 2025

Centene Corp (CNC) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategizing for ... - Yahoo Finance

Jul 26, 2025
pulisher
Jul 26, 2025

Centene Corp (CNC) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategizing for Future Profitability - GuruFocus

Jul 26, 2025
pulisher
Jul 26, 2025

Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus

Jul 26, 2025
pulisher
Jul 25, 2025

Centene bounces back after surprise quarterly loss sent it plunging in pre-market trading - Sherwood News

Jul 25, 2025
pulisher
Jul 25, 2025

Centene (CNC) Shares Drop After Q2 Earnings Miss Expectations - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Centene posts big loss in second quarter amid federal health care cuts - STLtoday.com

Jul 25, 2025
pulisher
Jul 25, 2025

Centene raises Wall Street optimism that Medicaid insurers can improve profits - Reuters

Jul 25, 2025
pulisher
Jul 25, 2025

Why Centene (CNC) Stock Is Trading Up Today - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Flags Surging ABA Costs as Medicaid Pressures Mount - Behavioral Health Business

Jul 25, 2025
pulisher
Jul 25, 2025

Centene's Q2 loss: Why health insurers face such big headwinds - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Intel, Tesla, Centene, Deckers, Charter: Stocks Making The Biggest Moves Today - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Centene (CNC) Faces Challenges with Q2 2025 Loss and Revenue Headwinds - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Earnings: Rising Medical Costs Constrain 2025 Outlook, but Growth Expected in 2026 - Morningstar

Jul 25, 2025
pulisher
Jul 25, 2025

Medical Expenses Erode Centene's Bottom Line In Rare Q2 Earnings Miss - Barchart.com

Jul 25, 2025
pulisher
Jul 25, 2025

Centene posts loss but promises profitability gains in 2026, shares rise By Reuters - Investing.com

Jul 25, 2025
pulisher
Jul 25, 2025

Medical Expenses Erode Centene's Bottom Line in Rare Q2 Earnings Miss - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Shooting for Margin Improvement in 2026, Despite New Regulatory Pressures - Morningstar

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Stock Showing Signs of Life After Revenue Beat - Schaeffer's Investment Research

Jul 25, 2025
pulisher
Jul 25, 2025

Centene stock plunges after surprise loss, soaring medical costs and weak 2025 outlook - Invezz

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Clocks First Quarterly Loss In 13 Years, Stock Volatile (UPDATED) - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Centene: Pricing In Complete Obliteration (NYSE:CNC) - Seeking Alpha

Jul 25, 2025
pulisher
Jul 25, 2025

Centene outlook, Pinnacle & Synovus, Deckers: Trending Tickers - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Lays Out Path to Boost 2026 Profit After ACA Stumbles - Bloomberg

Jul 25, 2025
pulisher
Jul 25, 2025

Centene reports $253M loss, stock continues slide - The Business Journals

Jul 25, 2025
pulisher
Jul 25, 2025

Centene reports surprise loss as medical costs rise; shares fall 14% - Latest news from Azerbaijan

Jul 25, 2025
pulisher
Jul 25, 2025

Centene Reports Unexpected Q2 Loss: But Retail Expects Stock To Close Higher - Stocktwits

Jul 25, 2025
pulisher
Jul 25, 2025

Centene posts surprise loss as medical costs surge, shares slump - Reuters

Jul 25, 2025
pulisher
Jul 25, 2025

Centene stock hits decade low after insurer reports rare loss on higher medical costs - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Intel, Centene and Charter Communications fall; Deckers rises - Investing.com

Jul 25, 2025
pulisher
Jul 25, 2025

Centene (CNC) Reports Q2 Loss, Tops Revenue Estimates - Yahoo.co

Jul 25, 2025
pulisher
Jul 25, 2025

Centene’s stock roars back as investors cheer the devil they know about guidance - MarketWatch

Jul 25, 2025

Centene Corp Stock (CNC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
healthcare_plans MOH
$164.19
price down icon 0.50%
$14.67
price up icon 1.52%
$11.86
price up icon 0.85%
$23.20
price up icon 0.39%
healthcare_plans HUM
$231.52
price down icon 2.71%
Cap:     |  Volume (24h):